Home > > > > Report Detail

Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

Publisher Name :
Date: 18-Aug-2016
No. of pages: 211
Inquire Before Buying

The antibody production market is projected to reach USD 13.28 billion by 2021 from USD 7.45 billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market comprises products required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration.

The consumables segment is expected to account for the largest share of the antibody production products market, by upstream processing. Media and reagents are the major consumables involved in the upstream processing of antibodies. Media contain compounds that help in regulating the cell cycle. Reagents and buffers aid in maintaining an optimal pH level. The mandatory requirement of changing consumable sets for every batch results in their repeat purchase, there by driving the growth of this market segment. Among the end users in the market, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the antibody production market, and register the highest CAGR during the forecast period. Pharmaceutical and biotechnology companies use antibody production equipment and consumables to produce therapeutic antibodies as well as to carry out R & D for developing novel immune therapies.

North America is expected to account for the largest share of the antibody production market in 2016, followed by Europe. The large share of the North America region can be attributed to the rising cancer incidence, government funding for medical research in the U.S., need for quality cancer treatment, and growth in the number of regulatory approvals and authorization for use of mAbs in Canada. Asia-Pacific is expected to witness the highest growth rate in the forecast period, mainly due to increasing government and private-sector investments in China’s life sciences market, increasing government initiatives and growing pharmaceutical industry in India, and infrastructural development along with government support for strong academic and commercial R&D in the rest of Asia-Pacific.

The antibody production market witnesses high competitive intensity as there are several large and many small firms with similar product offerings. These companies adopt various strategies (new product launches, agreements, partnerships, collaborations acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

The prominent players in the antibody production market include GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), Sigma-Aldrich Corporation (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), INTEGRA Biosciences AG (Switzerland), and FiberCell Systems Inc. (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios of the top players in the antibody production market. The report analyzes the market based on process, and end user

  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the antibody production market

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various antibody production across regions

  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the antibody production market

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the antibody production market.

Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Antibody Production Market Definition
1.3 Antibody Production Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Antibody Production Market Size Estimation Methodology
2.4 Antibody Production Market Forecast Methodology
2.5 Antibody Production Market Data Validation and Triangulation
2.6 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current and Future Scenario
3.3 Conclusion

4 Premium Insights
4.1 Antibody Production Market Overview
4.2 Antibody Production Market Size, By Process, 2016 vs 2021
4.3 Antibody Production Market Size, By End User, 2016 vs 2021

5 Market Overview
5.1 Introduction of Antibody Production Market
5.2 Antibody Production Market Segmentation
5.3 Antibody Production Market Dynamics
5.3.1 Drivers
5.3.1.1 U.S. Fda Clearance of Therapeutic Mabs
5.3.1.2 Increasing Adoption of Targeted Immunotherapy
5.3.1.3 Increasing R&D Expenditure in Pharmaceutical and Biotechnological Companies
5.3.1.4 Rising Number of Fast Track and Orphan Drug Designations
5.3.2 Restraints
5.3.2.1 Cost Constraints Related to the Adoption of Membrane Filters
5.3.3 Opportunities
5.3.3.1 Rising Demand for Protein Therapeutics
5.3.3.2 Increasing Risk of Infectious Diseases
5.3.3.3 Patent Expiry of Blockbuster Mabs
5.3.4 Challenges
5.3.4.1 High Costs of Primary Antibodies

6 Antibody Production Market, By Process
6.1 Introduction
6.2 Upstream Processing
6.2.1 Bioreactors
6.2.1.1 Large-Scale Bioreactors
6.2.1.2 Single-Use Bioreactors (SUBS)
6.2.2 Consumables
6.2.2.1 Media
6.2.2.2 Reagents and Buffers
6.3 Downstream Processing
6.3.1 Chromatography Instruments
6.3.2 Chromatography Resins
6.3.2.1 Affinity Chromatography Resins
6.4 Ion Exchange (IEX) Chromatography Resins
6.5 Hydrophobic Interaction Chromatography (HIC) Resins
6.6 Multimodal Chromatography Resins
6.7 Filtration
6.7.1 Filtration Systems
6.7.2 Filtration Consumables and Accessories

7 Antibody Production Market, By End User
7.1 Introduction
7.1.1 Pharmaceutical and Biotechnology Companies
7.1.2 Diagnostic Laboratories
7.1.3 Research Institutes

8 Global Antibody Production Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Cancer Incidence in the U.S.
8.2.1.2 Government Funding for Medical Research
8.2.1.3 Conferences, Symposia, and Seminars on Bioprocessing Technologies
8.2.2 Canada
8.2.2.1 Government Initiatives to Promote Research
8.2.2.2 Need for Quality Cancer Treatment
8.2.2.3 Regulatory Approvals and Authorization for Use of Mabs
8.3 Europe
8.3.1 Germany
8.3.1.1 Increasing Focus on R&D
8.3.1.2 Government Funding
8.3.2 U.K.
8.3.2.1 Flourishing Biotechnology and Biopharmaceutical Industry
8.3.3 France
8.3.3.1 Growing Presence of Chromatography Players in France
8.3.4 Rest of Europe (RoE)
8.3.4.1 Investments and Funding for Life Sciences to Bolster the Antibody Production Market
8.4 Asia-Pacific
8.4.1 Japan
8.4.1.1 Growing Biopharmaceutical Sector and Rise in Geriatric Population
8.4.2 China
8.4.2.1 Increasing Government and Private-Sector Investments in China’s Life Sciences Market
8.4.2.2 Outsourcing of Clinical Research Activities to China
8.4.3 India
8.4.3.1 Increasing Government Initiatives and Growing Pharmaceutical Industry in India
8.4.3.2 Development of Bioclusters to Boost India’s Biotechnology Industry
8.4.4 Rest of Asia-Pacific
8.4.4.1 Funding From the Australian Government for Scientific Research and Innovation
8.4.4.2 Infrastructural Development in Vietnam
8.4.4.3 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
8.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
8.5 Rest of the World
8.5.1 Latin America
8.5.1.1 Pharmaceutical, Biotechnology, and Research Industries in Brazil to Bolster the Market
8.5.1.2 Mexico, the Production Hub for Global Pharmaceutical Companies
8.5.2 Middle East and Africa (MEA)
8.5.2.1 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and Uae
8.5.2.2 Increasing Focus on Africa By Pharmaceutical Companies

9 Competitive Landscape
9.1 Antibody Production Market: Overview
9.2 Antibody Production Market: Strategic Overview
9.3 Competitive Situation and Trends
9.3.1 New Product Launches
9.3.2 Expansions
9.3.3 Agreements, Alliances, Partnerships, and Collaborations
9.3.4 Mergers and Acquisitions
9.3.5 Other Strategies

10 Company Profiles
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
10.1 Introduction
10.2 GE Healthcare (A SUBSidiary of General Electric Company)
10.3 Merck KGAA
10.4 Thermo Fisher Scientific, Inc.
10.5 Sartorius AG
10.6 Pall Corporation (Acquired By Danaher Corporation)
10.7 Sigma-Aldrich Corporation (Acquired By Merck KGAA)
10.8 Eppendorf AG
10.9 Cellab GmbH
10.10 Integra Biosciences AG
10.11 Fibercell Systems Inc.

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Insights of Industry Experts
11.2 Discussion Guide
11.3 Other Developments (2013–2016)
11.3.1 GE Healthcare
11.3.2 Merck KGAA
11.3.3 Thermo Fisher Scientific, Inc.
11.3.4 Sartorius AG
11.3.5 Sigma-Aldrich Corporation (Acquired By Merck KGAA)
11.3.6 Eppendorf AG
11.3.7 Integra Biosciences Group
11.4 Knowledge Store: Marketsandmarkets’ SUBScription Portal
11.5 Introducing RT: Real-Time Market Intelligence
11.6 Available Customizations
11.7 Related Reports

List of Tables

Table 1 Increasing Life Science R&D Expenditure is Propelling the Growth of the Antibody Production Market
Table 2 Cost Constraints Related to the Adoption of Membrane Filters to Restrain the Antibody Production Market
Table 3 Patent Expiry of Blockbuster Mabs Offers Huge Potential for the Antibody Production Market
Table 4 High Costs of Primary Antibodies Posing as A Challenge for the Growth of the Antibody Production Market
Table 5 Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 6 Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 7 Upstream Processing Market Size, By Region, 2014–2021 (USD Million)
Table 8 North America: Upstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 9 Europe: Upstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 10 Asia-Pacific: Upstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 11 RoW: Upstream Processing Market Size, By Region, 2014–2021 (USD Million)
Table 12 Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 13 Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 14 North America: Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 15 Europe: Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 16 Asia-Pacific: Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 17 RoW: Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 18 Large-Scale Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Large-Scale Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Large-Scale Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Large-Scale Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 22 RoW: Large-Scale Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 23 Single-Use Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Single-Use Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 25 Europe: Single-Use Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 26 Asia-Pacific: Single-Use Bioreactors Market Size, By Country, 2014–2021 (USD Million)
Table 27 RoW: Single-Use Bioreactors Market Size, By Region, 2014–2021 (USD Million)
Table 28 Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 29 Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 30 North America: Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 31 Europe: Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 32 Asia-Pacific: Consumables Market Size, By Country, 2014–2021 (USD Million)
Table 33 RoW: Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 34 Media Market Size, By Region, 2014–2021 (USD Million)
Table 35 North America: Media Market Size, By Country, 2014–2021 (USD Million)
Table 36 Europe: Media Market Size, By Country, 2014–2021 (USD Million)
Table 37 Asia-Pacific: Media Market Size, By Country, 2014–2021 (USD Million)
Table 38 RoW: Media Market Size, By Region, 2014–2021 (USD Million)
Table 39 Reagents and Buffers Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Reagents and Buffers Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Reagents and Buffers Market Size, By Country, 2014–2021 (USD Million)
Table 42 Asia-Pacific: Reagents and Buffers Market Size, By Country, 2014–2021 (USD Million)
Table 43 RoW: Reagents and Buffers Market Size, By Region, 2014–2021 (USD Million)
Table 44 Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 45 Downstream Processing Market Size, By Region, 2014–2021 (USD Million)
Table 46 North America: Downstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 47 Europe: Downstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 48 Asia-Pacific: Downstream Processing Market Size, By Country, 2014–2021 (USD Million)
Table 49 RoW: Downstream Processing Market Size, By Region, 2014–2021 (USD Million)
Table 50 Chromatography Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Chromatography Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 52 Europe: Chromatography Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 53 Asia-Pacific: Chromatography Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 54 RoW: Chromatography Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 55 Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 56 Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 57 North America: Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 58 Europe: Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 59 Asia-Pacific: Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 60 RoW: Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 61 Affinity Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 62 North America: Affinity Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 63 Europe: Affinity Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 64 Asia-Pacific: Affinity Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 65 RoW: Affinity Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 66 IEX Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 67 North America: IEX Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 68 Europe: IEX Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 69 Asia-Pacific: IEX Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 70 RoW: IEX Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 71 HIC Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 72 North America: HIC Resins Market Size, By Country, 2014–2021 (USD Million)
Table 73 Europe: HIC Resins Market Size, By Country, 2014–2021 (USD Million)
Table 74 Asia-Pacific: HIC Resins Market Size, By Country, 2014–2021 (USD Million)
Table 75 RoW: HIC Resins Market Size, By Region, 2014–2021 (USD Million)
Table 76 Multimodal Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 77 North America: Multimodal Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 78 Europe: Multimodal Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Multimodal Chromatography Resins Market Size, By Country, 2014–2021 (USD Million)
Table 80 RoW: Multimodal Chromatography Resins Market Size, By Region, 2014–2021 (USD Million)
Table 81 Filtration Market Size, By Type, 2014–2021 (USD Million)
Table 82 Filtration Market Size, By Region, 2014–2021 (USD Million)
Table 83 North America: Filtration Market Size, By Country, 2014–2021 (USD Million)
Table 84 Europe: Filtration Market Size, By Country, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Filtration Market Size, By Country, 2014–2021 (USD Million)
Table 86 RoW: Filtration Market Size, By Region, 2014–2021 (USD Million)
Table 87 Filtration Systems Market Size, By Region, 2014–2021 (USD Million)
Table 88 North America: Filtration Systems Market Size, By Country, 2014–2021 (USD Million)
Table 89 Europe: Filtration Systems Market Size, By Country, 2014–2021 (USD Million)
Table 90 Asia-Pacific: Filtration Systems Market Size, By Country, 2014–2021 (USD Million)
Table 91 RoW: Filtration Systems Market Size, By Region, 2014–2021 (USD Million)
Table 92 Filtration Consumables and Accessories Market Size, By Region, 2014–2021 (USD Million)
Table 93 North America: Filtration Consumables and Accessories Market Size, By Country, 2014–2021 (USD Million)
Table 94 Europe: Filtration Consumables and Accessories Market Size, By Country, 2014–2021 (USD Million)
Table 95 Asia-Pacific: Filtration Consumables and Accessories Market Size, By Country, 2014–2021 (USD Million)
Table 96 RoW: Filtration Consumables and Accessories Market Size, By Region, 2014–2021 (USD Million)
Table 97 Antibody Production Market Size, By End User, 2014-2021 (USD Million)
Table 98 Antibody Production Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 99 Antibody Production Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 100 Antibody Production Market Size for Research Institutes, By Region, 2014–2021 (USD Million)
Table 101 Antibody Production Market Size, By Region, 2014–2021 (USD Million)
Table 102 North America: Antibody Production Market Size, By Country, 2014–2021 (USD Million)
Table 103 North America: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 104 North America: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 105 North America: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 106 North America: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 107 North America: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 108 North America: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 109 North America: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 110 U.S.: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 111 U.S.: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 112 U.S.: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 113 U.S.: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 114 U.S.: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 115 U.S.: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 116 U.S.: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 117 Canada: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 118 Canada: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 119 Canada: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 120 Canada: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 121 Canada: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 122 Canada: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 123 Canada: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 124 Europe: Antibody Production Market Size, By Country, 2014–2021 (USD Million)
Table 125 Europe: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 126 Europe: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 127 Europe: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 128 Europe: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 129 Europe: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 130 Europe: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 131 Europe: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 132 Germany: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 133 Germany: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 134 Germany: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 135 Germany: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 136 Germany: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 137 Germany: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 138 Germany: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 139 U.K.: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 140 U.K.: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 141 U.K.: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 142 U.K.: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 143 U.K.: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 144 U.K.: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 145 U.K.: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 146 France: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 147 France: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 148 France: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 149 France: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 150 France: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 151 France: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 152 France: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 153 RoE: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 154 RoE: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 155 RoE: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 156 RoE: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 157 RoE: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 158 RoE: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 159 RoE: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 160 Asia-Pacific: Antibody Production Market Size, By Country, 2014–2021 (USD Million)
Table 161 Asia-Pacific: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 162 Asia-Pacific: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 163 Asia-Pacific: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 164 Asia-Pacific: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 165 Asia-Pacific: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 166 Asia-Pacific: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 167 Asia-Pacific: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 168 Japan: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 169 Japan: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 170 Japan: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 171 Japan: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 172 Japan: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 173 Japan: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 174 Japan: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 175 China: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 176 China: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 177 China: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 178 China: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 179 China: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 180 China: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 181 China: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 182 India: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 183 India: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 184 India: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 185 India: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 186 India: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 187 India: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 188 India: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 189 RoAPAC: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 190 RoAPAC: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 191 RoAPAC: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 192 RoAPAC: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 193 RoAPAC: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 194 RoAPAC: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 195 RoAPAC: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 196 RoW: Antibody Production Market Size, By Region, 2014–2021 (USD Million)
Table 197 RoW: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 198 RoW: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 199 RoW: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 200 RoW: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 201 RoW: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 202 RoW: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 203 RoW: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 204 Latin America: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 205 Latin America: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 206 Latin America: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 207 Latin America: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 208 Latin America: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 209 Latin America: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 210 Latin America: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 211 MEA: Antibody Production Market Size, By Process, 2014–2021 (USD Million)
Table 212 MEA: Upstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 213 MEA: Bioreactors Market Size, By Type, 2014–2021 (USD Million)
Table 214 MEA: Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 215 MEA: Downstream Processing Market Size, By Product, 2014–2021 (USD Million)
Table 216 MEA: Chromatography Resins Market Size, By Technique, 2014–2021 (USD Million)
Table 217 MEA: Filtration Market Size, By Product, 2014–2021 (USD Million)
Table 218 New Product Launches (2013–2016)
Table 219 Expansions (2013–2016)
Table 220 Agreements, Alliances, Partnerships, and Collaborations (2013–2016)
Table 221 Other Strategies (2013–2016)

List of Figures

Figure 1 Global Antibody Production Market Segmentation
Figure 2 Global Antibody Production Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Antibody Production Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Antibody Production Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design of Antibody Production Market
Figure 7 Data Triangulation Methodology
Figure 8 Global Antibody Production Market Size, By Process (2016 vs 2021)
Figure 9 Global Antibody Production Market Size, By End User, 2016 vs 2021
Figure 10 Asia-Pacific Market to Witness the Highest Growth Rate During the Forecast Period
Figure 11 North America to Command the Largest Share of the Antibody Production Market in 2016
Figure 12 Downstream Processing Segment to Witness the Highest Growth Rate From 2016 to 2021
Figure 13 Pharmaceutical & Biotechnology Companies Segment Will Continue to Dominate the Market in 2021
Figure 14 Antibody Production Market Segmentation
Figure 15 Drivers, Restraints, Opportunities, & Challenges
Figure 16 Approvals of Therapeutic Monoclonal Antibodies in the U.S. (1995-2015)
Figure 17 Downstream Processing to Command the Largest Share of the Antibody Production Market, By Process
Figure 18 Pharmaceutical and Biotechnology Companies End-User Segment to Grow at the Highest Rate During the Forecast Period
Figure 19 Antibody Production Market, By Region, 2016
Figure 20 North America: Antibody Production Market Snapshot
Figure 21 Europe: Antibody Production Market Snapshot
Figure 22 Asia-Pacific: Antibody Production Market Snapshot
Figure 23 RoW: Antibody Production Market Snapshot
Figure 24 Leading Market Players Adopted New Product Launches as Their Key Growth Strategy From 2013 to 2016
Figure 25 Battle for Antibody Production Market Share: New Product Launches Was the Key Strategy Adopted By Market Players (2013–2016)
Figure 26 New Product Launches, By Company (2013–2016)
Figure 27 Expansions, By Company (2013–2016)
Figure 28 Agreements, Alliances, Partnerships, and Collaborations (2013–2016)
Figure 29 Merger and Acquisitions, By Company (2013–2016)
Figure 30 Other Strategies, By Company (2013–2016)
Figure 31 Geographic Revenue Mix of the Prominent Players (2015)
Figure 32 GE Healthcare: Company Snapshot
Figure 33 Merck KGAA: Company Snapshot
Figure 34 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 35 Sartorius AG: Company Snapshot
Figure 36 Pall Corporation: Company Snapshot
Figure 37 Sigma-Aldrich Corporation: Company Snapshot
Figure 38 Eppendorf AG: Company Snapshot

  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs